Yahoo Finance10d
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
ASHBURN, Va., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty ...
Nasdaq8d
Quoin Pharmaceuticals prices 15.1M ADSs at 45c in public offering
Quoin Pharmaceuticals (QNRX) announced the pricing of its “reasonable best efforts” public offering of 15,111,110 ordinary shares represented by 15,111,110 American Depositary Shares, Series F ...
WSIL-TV25d
Boil order issued for parts of Du Quoin
DU QUOIN, Ill. (WSIL) -- A boil order has been issued for parts of Du Quoin. Waterworks and sewerage system superintendent Ron Darnell says that order is effective immediately. The order affects ...
Stockhouse8d
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
ASHBURN, Va., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty ...
Business Insider11d
Quoin Pharmaceuticals announces interim data from Netherton Syndrome studies
Quoin Pharmaceuticals (QNRX) announces interim clinical data from two of its ongoing Netherton Syndrome clinical studies. Data from the first subject being dosed twice-daily in Quoin’s ongoing ...
Nasdaq11d
Quoin Pharma's QRX003 Shows Promising Results In Netherton Syndrome Studies
(RTTNews) - Quoin Pharmaceuticals, Inc. (QNRX), a clinical-stage specialty pharmaceutical company, on Wednesday, announced positive interim data from two ongoing clinical trials for topical lotion ...
Yahoo Finance9d
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
Quoin Pharmaceuticals, Inc. ASHBURN, Va., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical ...